For those of you who missed the Australian Financial Reviews piece on KSX Jun08....here it is
A stock that could be well supported in the next few weeks is asthma diagnostic equipment developer Karmelsonix
Company representatives have been seen visiting clinicians and doctors in the United States with manufacturing giant Philips to introduce the Wheezometer device
Karmelsonix signed a letter of intent with Omron Healthcare last month to distrubute its products in Japan Russia and Brazil It is thought Omron and Philips are keen to sign a deal with Karmelsonix for the exclusive rights,and Philips is just weeks away from signing a letter of intent with the company The other question is whetherPhilips might find it less cumbersome to buy out Karmelsonix if the product proves to be a success,given Philips will probably want the right to distribute the device globally
KSX Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held